CalciMedica, Inc.

NASDAQ: CALC · Healthcare · Biotechnology

PublicHQ La Jolla, CACIK 0001534133Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH 17DQ —GM —SS 30

v0.1 · 35/100 weight · pillars only

↑ market scale, filing timeliness · ↓ Piotroski F, listing tenure

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$29.6M

Employees

Market cap

$15.3M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$29.6M-$29.6M2025

Operating income-$23.1M-$23.1M2025

Total assets$13.6M$13.6M2025

Liabilities$20.2M$20.2M2025

Equity-$6.6M-$6.6M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

CalciMedica, Inc. earned -$29.6M in FY2025 net income.

Peers · Healthcare

Conavi Medical Corp.——United Health Products, Inc.26D Passage Bio, Inc.——Anebulo Pharmaceuticals, Inc.——

Key facts

CEOA. Rachel Leheny

SectorHealthcare

IndustryBiotechnology

HeadquartersLa Jolla, CA

ExchangeNASDAQ: CALC

Employees14

IPO date2023-06-14

Latest filings

8-K2026-07-07 8-K2026-06-24 8-K2026-06-24 10-Q2026-05-12 8-K2026-05-12 8-K2026-03-18 8-K2026-03-03 10-K2026-03-03

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.